The subject invention is directed to the treatment of obstetrical disorders by administration of a sphingosine kinase inhibitor. Spingosine kinase inhibitors are useful in the management or treatment of obstetrical disorders resulting from inflammation such as preterm birth and preterm labor. The treatment may take a variety of forms and is intended for a variety of mammals, such as premature neonates to adult humans.
